Fig. 2. Feature similarities of the palbociclib ligand and the newly designed compounds 10a–d–13a–d as potent CDK4/6 inhibitors.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.